text: Yo, check it out, I got a story to tell,
  'Bout CD146, a molecule that's swell.
  It's a cell adhesion molecule, known as CD146,
  Overexpressed in cancers, causin' quite a scene.
  
  Ovarian cancer, yeah, it's got that flow,
  CD146 be showin' up, lettin' it know.
  But what 'bout cervical and endometrial types?
  CD146 overexpressed? Let's shine some light.
  
  In this study, we found some dope results,
  CD146 levels higher, no insults.
  In cervical and endometrial cells, it's true,
  Compared to normal tissues, CD146 breaks through.
  
  We used mAb AA4, an anti-CD146 mouse antibody,
  Specificity, sensitivity, it's all quality.
  Detectin' these cancers, it's got the moves,
  Positive predictive value, it approves.
  
  CD146 correlates with the cervical subtype,
  In endometrial cancer, histological grade, it's hype.
  Myometrial invasion, depth plays a role,
  CD146 expression, it takes control.
  
  Blood vessels, yo, CD146's got 'em surrounded,
  In cervical and endometrial cancer, it's astounded.
  Metastasis through the vascular system, it's the key,
  CD146 actively involved, that's what we see.
  
  This study's got implications, it's quite profound,
  CD146 mAb development, let's break new ground.
  Detectin' gynecological cancers, that's the aim,
  Combine it with traditional treatments, it's a game.
  
  Anti-CD146 immunotherapy, holdin' it tight,
  With chemo or radiotherapy, it takes flight.
  A promising approach, against cervical and endometrial strife,
  CD146 mAb, it's changin' the game, that's life.